Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
NCT Number: NCT00224094
This study compares the effects of 12 weeks of treatment with transdermal versus oral estrogen therapy on testsoterone levels and thyroid tests in healthy, naturally menopausal women.
Looking for future studies?
Notify Me42 year–70 year
Female
Interventional
Phase 4
Boston, Massachusetts, 02114, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 12 weeks
Time frame: 12 weeks
Time frame: 12 weeks
Watson Pharmaceuticals
Industry
A Comparison of Transdermal vs. Oral Estrogen Replacement Therapy on Androgen Levels and Thyroid Function in Naturally Menopausal Women
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07695051
Hot Flashes, Menopause
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07589335
African Americans, Community Health Workers
Atlanta, Georgia, United States
View Trial DetailsNCT07651566
Menopause, Pathologic Processes
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT02618148
Menopause
Ho Chi Minh City, Vietnam
View Trial Details